Daily Market Update- Equity 1 June 2023 | Globe Capital Market LTD.
01-Jun-2023
Daily Market Update- Equity 1 June 2023

The benchmark Nifty index settled lower at 18534 levels, down 100 points from its previous closing values.

Overview and Outlook

Global Market Update

  • US equity markets were down in range 0.41 to 0.63%
  • European equity markets also ended lower in range 1 to 1.56%
  • Asian equity markets are trading mix
  • SGX Nifty is down by 50 points (as on 8:25AM)

 

News highlights from across the globe

  • Asian Equity markets are trading mix after Wall Street closed lower as investors looked beyond the debt ceiling to instead focus on the path for interest rates and concern in earnings reports.
  • Comments from Federal Reserve Governor Philip Jefferson signaled the central bank is inclined to keep interest rates steady in June to assess the economic outlook.
  • The yield on 10-year treasuries in the U.S. was trading at 3.63%. Crude declined nearly 1% below $73-mark

 

Important news updates from the domestic front

  • Coal India: The government will sell up to 18.48 crore shares of the company, representing a 3% stake, via an offer for sale on June 1 and 2. The floor price of the offer has been pegged at Rs 225 per share.
  • MOIL increased prices of manganese ore grades BGF452, CHF473 and GMF569 by 10%, effective from June 1.
  • Tata Motors is looking to buy back external commercial bonds worth $250 million from bondholders.
  • HFCL will spend Rs 470 crore to expand its current optical fiber capacity to 33.9 million fiber kilometers per annum from 10 million fiber kilometers per annum at its manufacturing facility in Telangana.
  • Bank of India: The bank hiked the marginal cost of funds-based lending rates by five basis points across tenures, effective June 1.
  • Laurus Labs will acquire an additional 7.24% stake in Immunoadoptive Cell Therapy for Rs 80 crore. Some promoters and senior management of the company will also acquire a 0.54% stake in ImmunoACT for Rs 4 crore through secondary purchases. The company already holds a 26.62% stake in ImmunoACT.
  • Vinati Organics bought additional 65.97 lakh shares of subsidiary Veeral Organics for Rs 6.59 crore.

 

Nifty Overview & Outlook

The benchmark Nifty index settled lower at 18534 levels, down 100 points from its previous closing values.

Broader markets outperformed the benchmark as Small cap and Mid cap index were up over 1% & 0.35% respectively against a 0.53% decline in a frontline index.

Performance on the sectoral front was mix. Amongst them, Realty, Consumer Durable and Healthcare index were the top performers, rose 0.75% each. On the other hand, Oil & Gas, Metals and Financial Service index led the declines, settled lower in range of 0.75% to 1.26%.

Going ahead, we reiterate our bullish view on the Nifty and suggest traders to maintain buy on dips trading strategy till it is holding above 18200 levels on closing basis.

 

Derivatives Overview & Outlook

Yesterday, Nifty futures shed around 5% of open interest as long unwinding, Banknifty futures remained almost unchanged on open interest front and Finnifty futures added around 3% of open interest as short positions.

On sectoral front, long buildup was seen among Telecom, Capital Goods and Pharma stocks while some short buildup was seen among Metals stocks.

On options front, call writing was seen at multiple strikes and maximum positions are at 18500 PE and 18600 CE.

 

Institutional Trading Activity

Yesterday, FIIs bought stocks worth Rs 3406 Cr in the cash segment, sold stocks futures worth Rs 2114 Cr and also sold index futures worth Rs 2027 Cr. DIIs were net sellers in the cash segment to the tune of Rs 2529 Cr.

 

Nifty Futures, Banknifty Futures & Finnifty Futures Key Levels

Nifty – Resistances 18700-18750; Supports 18560-18480

Banknifty – Resistances 44425-44700; Supports 43980-43750

Finnifty – Resistances 19625-19700; Supports 19430-19350

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, ICEX and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

Globe Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. Rolex Finvest Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited and Lakshya Impex Private Limited  are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.